Qbiotics, page-1013

  1. Supertrooper844
    30 Posts.
    clock Created with Sketch.
    02/02/23
    10:30
    Post #: 66024727
    here is a list of biotech companies with emerging Head and Neck cancer Drugs Under Different Phases of Clinical Development

    • CLR 131: Cellectar Biosciences, Inc.
    • MEM-288: Memgen, Inc.
    • IK 175: Ikena Oncology
    • Tigilanol Tiglate: QBiotics Group Limited
    • BNT 113: BioNTech
    • Niraparib: GlaxoSmithKline
    • Atezolizumab: Hoffmann-La Roche
    • Xevinapant: Merck

    extract from an article https://www.openpr.com/news/2891022/head-and-neck-cancer-pipeline-drugs-and-companies-insight-report
    Likes Created with Sketch. 2  Upvote
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

FG1 Flynn Gold flags mid-grade drill hits and always eye-catching rock chips
right-arrow Created with Sketch.
GNX NSW approves J-POWER's $380M buyout of Genex Power, giving it ownership of QLD net zero project
right-arrow Created with Sketch.
1CG One Click Group surpasses $3M in revenue YTD with 40% growth
right-arrow Created with Sketch.
MCT Metalicity looking for offers on Admiral Bay zinc project
right-arrow Created with Sketch.
LKE Lake Resources implies news article on job cuts made up; non-core sales "not material" and no rule 15.7 breach
right-arrow Created with Sketch.
IMR Imricor raises $35M to pursue growth and expansion into Australia and NZ
right-arrow Created with Sketch.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.